• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gaps in the coverage of vitamin K prophylaxis among newborns in India: insights from secondary analysis of data from the Health Management Information System.印度新生儿维生素 K 预防措施覆盖范围存在差距:来自健康管理信息系统数据的二次分析见解。
Public Health Nutr. 2021 Dec;24(17):5589-5597. doi: 10.1017/S1368980021003670. Epub 2021 Aug 25.
2
Factors associated with inadequate receipt of components and non-use of antenatal care services in India: a regional analysis.印度与产前保健服务组件接受不足和未使用相关的因素:区域分析。
BMC Public Health. 2023 Jan 3;23(1):6. doi: 10.1186/s12889-022-14812-3.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.采用叶绿醌新型混合微乳制剂对新生儿进行口服维生素K1预防:瑞士的3年经验
Eur J Pediatr. 1999 Jul;158(7):599-602. doi: 10.1007/s004310051155.
5
Vitamin A supplementation among 9-59 month old children in India: geospatial perspectives and implications for targeted coverage.印度 9-59 月龄儿童的维生素 A 补充:地理空间视角与针对性覆盖的影响。
BMJ Glob Health. 2022 Jul;7(7). doi: 10.1136/bmjgh-2021-007972.
6
Can prenatal vitamin K1 (phylloquinone) supplementation replace prophylaxis at birth?产前补充维生素K1(叶绿醌)能否替代出生时的预防措施?
Obstet Gynecol. 1993 Feb;81(2):251-4.
7
Changes in hepatic vitamin K1 levels after prophylactic administration to the newborn.新生儿预防性给药后肝脏维生素K1水平的变化。
J Pediatr Gastroenterol Nutr. 1993 Jan;16(1):10-4.
8
Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) status in newborns during the first week of life.新生儿出生后第一周内维生素K1(叶绿醌)和维生素K2(甲萘醌)的状况。
Pediatrics. 1988 Jan;81(1):137-40.
9
Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.印度 15 个邦的糖尿病和糖尿病前期患病率:ICMR-INDIAB 基于人群的横断面研究结果。
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. doi: 10.1016/S2213-8587(17)30174-2. Epub 2017 Jun 7.
10
Analysis of chromosome aberrations and sister chromatid exchanges in peripheral blood lymphocytes of newborns after vitamin K prophylaxis at birth.出生时维生素K预防后新生儿外周血淋巴细胞染色体畸变及姐妹染色单体交换分析
Pediatr Res. 1991 Dec;30(6):550-3. doi: 10.1203/00006450-199112000-00011.

引用本文的文献

1
Coverage of antenatal iron-folic acid and calcium distribution during pregnancy and their contextual determinants in the northeastern region of India.印度东北地区孕期产前铁叶酸和钙的覆盖情况及其背景因素
Front Nutr. 2022 Jul 18;9:894245. doi: 10.3389/fnut.2022.894245. eCollection 2022.

本文引用的文献

1
Current perspectives and practices of newborn vitamin K administration in low and middle income countries.低收入和中等收入国家新生儿维生素K给药的现状与实践
Res Rep Neonatol. 2018 Apr 5;8:45-51. doi: 10.2147/RRN.S154652.
2
Vitamin K Deficiency Bleeding in Infancy.婴儿期维生素 K 缺乏性出血。
Nutrients. 2020 Mar 16;12(3):780. doi: 10.3390/nu12030780.
3
Delivering neonatal vitamin K prophylaxis: the continuing need for surveillance and vigilance.提供新生儿维生素K预防措施:持续需要监测和警惕。
Arch Dis Child. 2020 May;105(5):417-418. doi: 10.1136/archdischild-2019-318117. Epub 2020 Feb 14.
4
Refusal of Intramuscular Vitamin K by Parents of Newborns: A Review.新生儿父母拒绝肌内注射维生素K:一项综述
Hosp Pediatr. 2020 Mar;10(3):286-294. doi: 10.1542/hpeds.2019-0228. Epub 2020 Feb 4.
5
Vitamin K deficiency bleeding in Australian infants 1993-2017: an Australian Paediatric Surveillance Unit study.澳大利亚婴幼儿维生素 K 缺乏性出血 1993-2017 年:澳大利亚儿科监测单位研究。
Arch Dis Child. 2020 May;105(5):433-438. doi: 10.1136/archdischild-2018-316424. Epub 2019 Sep 13.
6
Hepatitis B vaccination coverage across India: exploring the spatial heterogeneity and contextual determinants.印度各地的乙型肝炎疫苗接种覆盖率:探索空间异质性和背景决定因素。
BMC Public Health. 2019 Sep 12;19(1):1263. doi: 10.1186/s12889-019-7534-2.
7
Spontaneous intracranial haemorrhage in children-intensive care needs and predictors of in-hospital mortality: a 10-year single-centre experience.儿童自发性颅内出血——重症监护需求及院内死亡的预测因素:一项为期10年的单中心经验
Childs Nerv Syst. 2019 Aug;35(8):1371-1379. doi: 10.1007/s00381-019-04209-w. Epub 2019 Jun 4.
8
Vitamin K Prophylaxis: Is There a Need for Policy Change?维生素K预防:是否需要政策变革?
Indian J Pediatr. 2019 Nov;86(11):975-976. doi: 10.1007/s12098-019-02976-7. Epub 2019 May 23.
9
Child Health Policies in India: Moving from a Discernible Past to a Promising Future.印度的儿童健康政策:从可辨别的过去迈向充满希望的未来。
Indian J Pediatr. 2019 Jun;86(6):520-522. doi: 10.1007/s12098-019-02968-7. Epub 2019 Apr 29.
10
Newborn Vitamin K Prophylaxis: A Historical Perspective to Understand Modern Barriers to Uptake.新生儿维生素K预防:理解现代接受障碍的历史视角
Hosp Pediatr. 2019 Jan;9(1):55-60. doi: 10.1542/hpeds.2018-0104.

印度新生儿维生素 K 预防措施覆盖范围存在差距:来自健康管理信息系统数据的二次分析见解。

Gaps in the coverage of vitamin K prophylaxis among newborns in India: insights from secondary analysis of data from the Health Management Information System.

机构信息

Haematology Division, ICMR - Regional Medical Research Centre, North East Region, Dibrugarh 786010, Assam (Department of Health Research, Ministry of Health & Family Welfare, Government of India).

出版信息

Public Health Nutr. 2021 Dec;24(17):5589-5597. doi: 10.1017/S1368980021003670. Epub 2021 Aug 25.

DOI:10.1017/S1368980021003670
PMID:34431473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10195602/
Abstract

OBJECTIVE

Despite operational guidelines, anecdotal evidence suggests that newborn vitamin K1 prophylaxis is not practiced routinely in India. This study determined the coverage of vitamin K1 prophylaxis among newborns in the country.

DESIGN

Nationwide cross-sectional data on live births and newborns receiving vitamin K1 during the 2019-2020 reporting period were abstracted from the Health Management Information System (HMIS). The coverage estimates of newborn vitamin K1 prophylaxis were derived nationally and also for individual states and union territories (UT). Additionally, coverage heterogeneities were investigated using classifiers, viz. geography, socio-demographic index (SDI), special developmental categories and institutional birth rate (IBR).

SETTING

India.

PARTICIPANTS

20 208 804 newborns documented with HMIS.

RESULTS

Vitamin K1 was administered to overall 62·36 % newborns (95 % CI: 62·34 to 62·38 %). The Central zone (49·0 %), low SDI states (54·39 %), Empowered Action Group states (53·32 %) and states with low IBR (44·69 %) had the lowest coverage amongst their respective groupings. Across the individual states and UT, the coverage ranged widely from 22·18 % (in Tripura) to 99·38 % (in Puducherry), exhibiting considerable variability (coefficient of variation: 33·74 %) and inequality (Gini coefficient: 0·17). While the coverage in eight states/UT (i.e. Arunachal Pradesh, Manipur, Nagaland, Tripura, Uttar Pradesh, Uttarakhand, Telangana and Andaman & Nicobar Islands) was below 50 %; only five states/UT (i.e. Chandigarh, Gujarat, Goa, Puducherry and Tamil Nadu) achieved above 90 % coverage.

CONCLUSION

Vitamin K1 prophylaxis was not practiced in more than one-third newborns in India. It calls for identifying the barriers, addressing the gaps and implementing newborn vitamin K1 prophylaxis more effectively throughout the country.

摘要

目的

尽管有操作指南,但传闻证据表明,印度并未常规实施新生儿维生素 K1 预防措施。本研究旨在确定该国新生儿中维生素 K1 预防措施的覆盖率。

设计

从健康管理信息系统(HMIS)中提取了 2019-2020 报告期内活产儿和接受维生素 K1 的新生儿的全国性横断面数据。全国范围内以及各个邦和联邦属地(UT)的新生儿维生素 K1 预防措施覆盖率的估计值都是通过分类器(即地理位置、社会人口指数(SDI)、特殊发育类别和机构出生率(IBR))计算得出的。

地点

印度。

参与者

20208804 名记录在 HMIS 中的新生儿。

结果

维生素 K1 已在总体 62.36%的新生儿中使用(95%CI:62.34-62.38%)。中央邦(49.0%)、SDI 较低的邦(54.39%)、赋权行动小组邦(53.32%)和 IBR 较低的邦(44.69%)在各自的分组中覆盖率最低。在各个邦和 UT 中,覆盖率差异很大,从 22.18%(特里普拉邦)到 99.38%(本地治里邦),差异很大(变异系数:33.74%)且不平等(基尼系数:0.17)。虽然有 8 个邦/UT(即阿鲁纳恰尔邦、曼尼普尔邦、那加兰邦、特里普拉邦、北方邦、北阿坎德邦、特伦甘纳邦和安达曼和尼科巴群岛)的覆盖率低于 50%;但只有 5 个邦/UT(即昌迪加尔邦、古吉拉特邦、果阿邦、本地治里邦和泰米尔纳德邦)的覆盖率超过 90%。

结论

印度超过三分之一的新生儿未接受维生素 K1 预防措施。这需要确定障碍,解决差距,并在全国范围内更有效地实施新生儿维生素 K1 预防措施。